Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

209 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Recruiting

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

NCT05126472

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

NCT04752722

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +16 more
Locations
  • The University of Alabama at Birmingham Clinical Research Unit (CRU) Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Urological Associates of South Arizona Tucson, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 102 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

NCT07000084

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 58 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Humanitas Gavezzeni-Bergamo Bergamo, Italy
  • Ospedale Sant'Orsola - Malpighi Bologna, Italy
  • Policlinico Ospedali Riuniti - Foggia Foggia, Italy
  • Istituto Oncologico Veneto IRCCS Padova, Italy
View Trial Details
Recruiting

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

NCT07225127

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions